Company Filing History:
Years Active: 2000-2003
Title: Innovator Mark Gibson: Pioneering Pressurized Aerosol Compositions
Introduction
Mark Gibson, an inventive mind based in Shepshed, GB, has made significant contributions to the world of pharmaceutical innovations. With a focus on developing advanced aerosol compositions for medicinal delivery, he holds two patents that reflect his dedication to improving healthcare outcomes.
Latest Patents
Gibson’s latest patents demonstrate his expertise in pressurized aerosol technologies. The first patent involves "Pressurized aerosol compositions comprising powdered medicament dispersed in hydrofluoroalkane." This patent outlines a unique formulation for administering medication via inhalation, utilizing liquefied hydrofluoroalkane and innovative polymers to create an effective delivery system. His second patent, titled "Pressurized aerosol inhalation compositions," consists of a similar formulation that integrates polyvinylpyrrolidone to enhance the stability and suspension of powdered medicaments in the aerosol composition. Both patents represent a significant leap in inhalation therapies and highlight Gibson's commitment to medical innovation.
Career Highlights
Gibson's career has been marked by his work at Fisons Ltd., where he has applied his knowledge in developing aerosol delivery systems. His focus on creating efficient and effective means of administering therapeutics showcases his ability to merge scientific research with practical application. Mark's innovative spirit not only drives his projects but also contributes to the advancement of pharmaceutical science.
Collaborations
Throughout his career, Mark Gibson has collaborated with talented professionals such as Suresh N Mistry, enhancing the creative process and broadening the scope of their projects. Together, they have worked on developing novel solutions that address key challenges in aerosol medication delivery. These collaborations have fostered an environment of innovation, further pushing the boundaries of what is possible in the realm of pharmaceuticals.
Conclusion
Mark Gibson's work exemplifies the spirit of innovation in the field of inhalation therapies. With his two patents, he has made a lasting impact on the aerosol composition industry, demonstrating the importance of effective medication delivery. As he continues to collaborate with other experts in the field, the future holds great promise for further advancements in healthcare driven by his innovative contributions.